期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
经阴道三维超声检测最大肿瘤直径联合外周血鳞状上皮细胞癌抗原水平对局部晚期及晚期宫颈癌的诊断价值 被引量:1
1
作者 高璐璐 席登峰 +7 位作者 祖逸峥 陈华 苏育欣 靳雁 李贝 张瑞琪 张少华 哈春芳 《新乡医学院学报》 CAS 2023年第3期224-229,共6页
目的探讨经阴道三维超声检测最大肿瘤直径(MTD)联合外周血鳞状上皮细胞癌抗原(SCC-Ag)水平对局部晚期及晚期宫颈癌的诊断价值。方法选择2020年10月至2022年1月宁夏医科大学总医院收治的204例宫颈癌患者为研究对象。年龄26~80(51.82±... 目的探讨经阴道三维超声检测最大肿瘤直径(MTD)联合外周血鳞状上皮细胞癌抗原(SCC-Ag)水平对局部晚期及晚期宫颈癌的诊断价值。方法选择2020年10月至2022年1月宁夏医科大学总医院收治的204例宫颈癌患者为研究对象。年龄26~80(51.82±11.00)岁;国际妇产科联盟(FIGO)分期≤ⅡA期130例,≥ⅡB期74例;宫颈鳞状细胞癌166例,非鳞状细胞癌38例;低/中分化58例,高分化146例。采用经阴道三维超声检测患者首次诊断时的MTD,免疫化学发光法检测治疗前患者外周血SCC-Ag水平。比较不同FIGO分期、组织类型、分化程度患者的MTD及外周血SCC-Ag水平,分析MTD、SCC-Ag与宫颈癌FIGO分期、组织类型、分化程度的相关性;采用受试者操作特征(ROC)曲线分析MTD、SCC-Ag单独和联合对≥ⅡB期宫颈癌的诊断效能。结果≥ⅡB期组患者的外周血SCC-Ag水平显著高于≤ⅡA期组,MTD显著大于≤ⅡA期组(P<0.05)。鳞状细胞癌组患者的外周血SCC-Ag水平显著高于非鳞状细胞癌组(P<0.05);非鳞状细胞癌组患者SCC-Ag阳性13例(34.2%),鳞状细胞癌组患者SCC-Ag阳性111例(66.9%),非鳞状细胞癌组患者SCC-Ag阳性率显著低于鳞癌组(χ^(2)=13.834,P<0.05)。鳞状细胞癌组与非鳞状细胞癌组患者的MTD比较差异无统计学意义(P>0.05)。低/中分化组患者的MTD显著大于高分化组(P<0.05),2组患者的外周血SCC-Ag水平比较差异无统计学意义(P>0.05)。SCC-Ag、MTD与FIGO分期呈正相关(r=0.484、0.544,P<0.05);MTD与分化程度呈负相关(r=-0.166,P<0.05),SCC-Ag与分化程度无相关性(r=-0.027,P>0.05)。SCC-Ag、MTD单独诊断≥ⅡB期宫颈癌的ROC曲线下面积(AUC)分别为0.790、0.824,SCC-Ag与MTD联合诊断≥ⅡB期宫颈癌的AUC为0.855;SCC-Ag联合MTD诊断≥ⅡB期宫颈癌的AUC显著大于单独SCC-Ag、MTD诊断(Z=1.956、2.152,P<0.05);单独SCC-Ag与单独MTD诊断≥ⅡB期宫颈癌的AUC比较差异无统计学意义(Z=0.789,P>0.05)。结论宫颈癌患者治疗前外周血SCC-Ag水平可作为宫颈癌分期的参考指标,MTD可评估宫颈癌的分化程度及分期;SCC-Ag与MTD联合对局部晚期及晚期宫颈癌的诊断价值较大。 展开更多
关键词 宫颈癌 鳞状上皮细胞癌抗原 阴道三维超声 最大肿瘤直径
下载PDF
Laparoscopic hepatectomy for liver neoplasms in 15 cases
2
作者 Dongfang Huang Jinsheng Wu +11 位作者 Jianhuai Zhang Shaochuang Wang Lei Liu Fuzhen Qi Dianhua Gu Yebo Wang Ling Liu Guofeng Chen Ping Wang Gang Xu Yong Sun Yong Cai 《The Chinese-German Journal of Clinical Oncology》 CAS 2012年第5期257-260,共4页
Objective: The aim of our study was to retrospectively analyze 15 patients' clinical materials with laparoscopic resection of liver neoplasms. Methods: From December 2007, a total of 15 patients with liver neoplasm... Objective: The aim of our study was to retrospectively analyze 15 patients' clinical materials with laparoscopic resection of liver neoplasms. Methods: From December 2007, a total of 15 patients with liver neoplasms were performed with laparoscopic hepatectomy, and their clinical materials, perioperative dates, postoperative complications, postoperative recovery and short-term curative effects were analyzed and summarized respectively. Results: Laparoscopic hepatectomy (LH) were performed in 15 patients, including 1 case underwent laparoscopic hepatic left Iobectomy, 1 case of left lateral hepatectomy, 13 cases of partial liver resection. Fourteen cases of total laparoscopic liver resections for liver neoplasms, 1 case of hand-assisted laparoscopic liver resection of the tumor, there was no conversion to open approach. Of the 15 patients with liver neoplasms, 13 cases of hepatic neoplasms with the maximum diameter was 8 cm× 8 cm × 9 cm, 9 cases of the borderline micro hepatocellular carcinoma (MHCC) with the diameter not more than 2 cm, 3 cases of hepatic benign tumor. The mean operation time was (120 ± 30) min, and the intraoperative average hemorrhage was 100 mL, beginning to eat and get out of bed following 1-2 days of operation. The average postoperative hospitalization was 8 days, WBC, ALl', AST, albumin, bilirubin returned to normal after one week of operation. There were no postoperative complications such as hemorrhage, bile leakage or air embolism etc. Twelve patients with HCC were confirmed by postoperative pathology, 1 case of liver smooth muscle lipoma, 2 case of hepatic hemangioma. By one year of followed-up in 12 cases of HCC, the longest survival was 38 months, and no recurrence or death, 1 year survival rate was 100%. Conclusion: Among the choice of cases, the advantages of LH for liver neoplasms compared with open surgery were less trauma, faster recovery and less blood loss. it is safe and effective for choosing a reasonable surgical indication, especially for peripheral micro hepatocellular carcinoma. 展开更多
关键词 HEPATECTOMY LAPAROSCOPE liver neoplasms
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部